- Home
- TIPT vs LXRX Comparison
TIPT vs LXRX Comparison
Compare TIPT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIPT | LXRX |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 653.2M | 547.4M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TIPT | LXRX |
|---|---|---|
| Price | $16.85 | $1.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.15 |
| AVG Volume (30 Days) | 255.6K | ★ 2.6M |
| Earning Date | 03-06-2026 | 03-05-2026 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | ★ 0.76 | N/A |
| Revenue | $488,000.00 | ★ $49,803,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.93 | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $15.49 | $0.36 |
| 52 Week High | $27.38 | $1.83 |
Technical Indicators
Market Signals| Indicator | TIPT | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 44.86 |
| Support Level | $16.41 | $1.47 |
| Resistance Level | $18.15 | $1.65 |
| Average True Range (ATR) | 0.36 | 0.11 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 97.18 | 2.93 |
Price Performance
Historical ComparisonAbout TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.